Actively Recruiting
Study to Collect Blood Samples and Clinical Data from Adults Diagnosed with Hypersensitivity Pneumonitis
Led by Nils Hoyer · Updated on 2023-12-22
50
Participants Needed
1
Research Sites
208 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying patients diagnosed with hypersensitivity pneumonitis HP to collect blood samples and regular clinical data. This observational study is a sub-study of the main Pulmonary Fibrosis Biomarker PFBIO cohort, which includes patients with idiopathic pulmonary fibrosis IPF. The study aims to assess biomarkers for diagnosis and prognosis and to explore further subtyping of HP based on blood markers, including precipitins. Participants diagnosed with HP by a multidisciplinary team MDT according to current international guidelines are included if they are 18 years or older and able to give informed consent. The study involves collecting blood samples and clinical information over time, with data stored in a database and biobank for future HP research and comparison to the main PFBIO cohort. Participants will be followed for up to three years, during which researchers will measure diagnosis, exposure to inciting antigens, progression-free survival, and overall survival. Quality of life questionnaires, pulmonary function tests, and imaging will also be conducted regularly to monitor participants health and disease progression. The collected data will help improve understanding of HP and support future studies.
CONDITIONS
Brief Title
Database and Biobank of Patients With Hypersensitivity Pneumonitis
Research Team
N
Nils Hoyer, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here